James Lohr

Title(s)Senate Emeritus, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Lohr received his BA from the University of Chicago and MD from the Pritzker School of Medicine at the University of Chicago. From there, he went to the University of Pittsburgh where he completed his residency in General Psychiatry at the Western Psychiatric Institute and Clinics, and then completed a Neuropsychiatry Fellowship at the National Institute of Mental Health in Washington DC. He joined the Department of Psychiatry faculty at UCSD in 1987, and for 12 years was the Chief of Psychiatry at the VA San Diego Healthcare System. For the last three years he has been Vice Chair for Clinical Affairs in the Department of Psychiatry at UCSD, and Clinical Service Chief for the Department as well. He oversees the clinical operations for all mental health services at UCSD. He is also the Director of the Psychopharmacology Research Initiatives Center of Excellence (PRICE) in the Department of Psychiatry, which coordinates studies of psychotropic medications.

    Research Interests

    Dr. Lohr’s primary research interest has been neuropsychiatric movement disorders and the major psychotic illnesses of schizophrenia and bipolar disorder. He has been involved in studies of motor function, brain imaging, oxidative metabolism, and lateralized hemispheric functioning in these disorders, as well as studies of psychopharmacology and of healthcare systems and delivery.

    Clinical Focus

    Dr. Lohr’s primary clinical focus is on serious mental disorders, predominantly the major psychotic disorders of schizophrenia, schizoaffective disorder, and bipolar disorder.

    Collapse Research 
    Collapse Research Activities and Funding
    Accelerated Aging among Veterans with PTSD
    NIH I01CX001351Apr 1, 2017 - Mar 31, 2021
    Role: Principal Investigator
    MOTOR/COGNITIVE ASYMMETRY IN OLDER PSYCHOTIC PATIENTS
    NIH/NIMH R01MH057140Sep 1, 1998 - May 31, 2003
    Role: Principal Investigator
    TARDIVE DYSKINESIA: FREE RADICAL MECHANISMS &VITAMIN E
    NIH/NIMH R29MH045142Aug 1, 1989 - Jul 31, 1994
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature. Am J Geriatr Psychiatry. 2015 Jul; 23(7):709-25. Lohr JB, Palmer BW, Eidt CA, Aailaboyina S, Mausbach BT, Wolkowitz OM, Thorp SR, Jeste DV. PMID: 25959921; PMCID: PMC4568841.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    2. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study. Schizophr Res. 2013 Oct; 150(1):289-96. Lohr JB, Liu L, Caligiuri MP, Kash TP, May TA, Murphy JD, Ancoli-Israel S. PMID: 23938173.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    3. Quantitative assessment of motor abnormalities in untreated patients with major depressive disorder. J Affect Disord. 2013 Mar 20; 146(1):84-90. Lohr JB, May T, Caligiuri MP. PMID: 22985485; PMCID: PMC4283485.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    4. Oxidative mechanisms and tardive dyskinesia. CNS Drugs. 2003; 17(1):47-62. Lohr JB, Kuczenski R, Niculescu AB. PMID: 12467492.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    5. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394. J Clin Psychopharmacol. 2002 Apr; 22(2):196-200. Lohr JB, Caligiuri MP, Edson R, Lavori P, Adler LA, Rotrosen J, Hitzemann R. PMID: 11910266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans